|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Fedewa SA, Miller KD,
Goding-Sauer A, Pinheiro PS, Martinez-Tyson D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2015. CA Cancer J Clin.
65:457–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoyne G, Rudnicka C, Sang QX, Roycik M,
Howarth S, Leedman P, Schlaich M, Candy P and Matthews V: Genetic
and cellular studies highlight that A Disintegrin and
Metalloproteinase 19 is a protective biomarker in human prostate
cancer. BMC Cancer. 16:1512016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marzec J, Mao X, Li M, Wang M, Feng N, Gou
X, Wang G, Sun Z, Xu J, Xu H, et al: A genetic study and
meta-analysis of the genetic predisposition of prostate cancer in a
Chinese population. Oncotarget. 7:21393–21403. 2016.PubMed/NCBI
|
|
5
|
Zhou C, Dai X, Chen Y, Shen Y, Lei S, Xiao
T, Bartfai T, Ding J and Wang MW: G protein-coupled receptor GPR160
is associated with apoptosis and cell cycle arrest of prostate
cancer cells. Oncotarget. 7:12823–12839. 2016.PubMed/NCBI
|
|
6
|
Orr B, Riddick AC, Stewart GD, Anderson
RA, Franco OE, Hayward SW and Thomson AA: Identification of
stromally expressed molecules in the prostate by tag-profiling of
cancer-associated fibroblasts, normal fibroblasts and fetal
prostate. Oncogene. 31:1130–1142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ono M, Ohkouchi S, Kanehira M, Tode N,
Kobayashi M, Ebina M, Nukiwa T, Irokawa T, Ogawa H, Akaike T, et
al: Mesenchymal stem cells correct inappropriate
epithelial-mesenchyme relation in pulmonary fibrosis using
stanniocalcin-1. Mol Ther. 23:549–560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohkouchi S, Ono M, Kobayashi M, Hirano T,
Tojo Y, Hisata S, Ichinose M, Irokawa T, Ogawa H and Kurosawa H:
Myriad functions of stanniocalcin-1 (STC1) cover multiple
therapeutic targets in the complicated pathogenesis of idiopathic
pulmonary fibrosis (IPF). Clin Med Insights Circ Respir Pulm Med.
9:(Suppl 1). S91–S96. 2015.
|
|
9
|
Lee S, Naesens M, Li L and Sarwal M:
Stanniocalcin supports the functional adaptation of adult-sized
kidneys transplanted into the pediatric recipients.
Transplantation. 93:1130–1135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang SE, Wu CP, Wu SY, Peng CK, Perng WC,
Kang BH, Chu SJ and Huang KL: Stanniocalcin-1 ameliorates
lipopolysaccharide-induced pulmonary oxidative stress,
inflammation, and apoptosis in mice. Free Radic Biol Med.
71:321–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Law AY and Wong CK: Stanniocalcin-2 is a
HIF-1 target gene that promotes cell proliferation in hypoxia. Exp
Cell Res. 316:466–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Yang XH, Fang SJ, Qin CF, Sun RL,
Liu ZY, Jiang BY, Wu X and Li G: HOXA7 stimulates human
hepatocellular carcinoma proliferation through cyclin E1/CDK2.
Oncol Rep. 33:990–996. 2015.PubMed/NCBI
|
|
13
|
Peña C, Céspedes MV, Lindh MB, Kiflemariam
S, Mezheyeuski A, Edqvist PH, Hägglöf C, Birgisson H, Bojmar L,
Jirström K, et al: STC1 expression by cancer-associated fibroblasts
drives metastasis of colorectal cancer. Cancer Res. 73:1287–1297.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma X, Gu L, Li H, Gao Y, Li X, Shen D,
Gong H, Li S, Niu S, Zhang Y, et al: Hypoxia-induced overexpression
of stanniocalcin-1 is associated with the metastasis of early stage
clear cell renal cell carcinoma. J Transl Med. 13:562015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou H, Li YY, Zhang WQ, Lin D, Zhang WM
and Dong WD: Expression of stanniocalcin-1 and stanniocalcin-2 in
laryngeal squamous cell carcinoma and correlations with clinical
and pathological parameters. PLoS One. 9:e954662014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu G, Yang G, Chang B, Mercado-Uribe I,
Huang M, Zheng J, Bast RC, Lin SH and Liu J: Stanniocalcin 1 and
ovarian tumorigenesis. J Natl Cancer Inst. 102:812–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du YZ, Gu XH, Li L and Gao F: The
diagnostic value of circulating stanniocalcin-1 mRNA in non-small
cell lung cancer. J Surg Oncol. 104:836–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang AC, Doherty J, Huschtscha LI,
Redvers R, Restall C, Reddel RR and Anderson RL: STC1 expression is
associated with tumor growth and metastasis in breast cancer. Clin
Exp Metastasis. 32:15–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park WY, Hong BJ, Lee J, Choi C and Kim
MY: H3K27 demethylase JMJD3 employs the NF-κB and BMP signaling
pathways to modulate the tumor microenvironment and promote
melanoma progression and metastasis. Cancer Res. 76:161–170. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu J, Law AY, Yeung BH and Wong CK:
Activation of gill Ca2+-sensing receptor as a protective
pathway to reduce Ca2+-induced cytotoxicity. J Mol
Endocrinol. 53:155–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi X, Wang J and Qin Y: Recombinant
adeno-associated virus-delivered hypoxia-inducible stanniocalcin-1
expression effectively inhibits hypoxia-induced cell apoptosis in
cardiomyocytes. J Cardiovasc Pharmacol. 64:522–529. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagappan A, Lee HJ, Saralamma VV, Park HS,
Hong GE, Yumnam S, Raha S, Charles SN, Shin SC, Kim EH, et al:
Flavonoids isolated from Citrus platymamma induced G2/M cell
cycle arrest and apoptosis in A549 human lung cancer cells. Oncol
Lett. 12:1394–1402. 2016.PubMed/NCBI
|
|
23
|
Huang Y, Zhao S, Zhang Y, Zhang C and Li
X: Downregulation of coding transmembrane protein 35 gene inhibits
cell proliferation, migration and cell cycle arrest in osteosarcoma
cells. Exp Ther Med. 12:581–588. 2016.PubMed/NCBI
|
|
24
|
Tsai TC, Huang HP, Chang KT, Wang CJ and
Chang YC: Anthocyanins from roselle extract arrest cell cycle G2/M
phase transition via ATM/Chk pathway in p53-deficient leukemia
HL-60 cells. Environ Toxicol. Jul 22–2016.(Epub ahead of print).
doi: 10.1002/tox.22324.
|
|
25
|
Huang MY, Xuan F, Liu W and Cui HJ: MINA
controls proliferation and tumorigenesis of glioblastoma by
epigenetically regulating cyclins and CDKs via H3K9me3
demethylation. Oncogene. Jun 13–2016.(Epub ahead of print). doi:
10.1038/onc.2016.208.
|
|
26
|
Hydbring P, Malumbres M and Sicinski P:
Non-canonical functions of cell cycle cyclins and cyclin-dependent
kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Azevedo WF: Opinion paper: Targeting
multiple cyclin-dependent kinases (CDKs): A new strategy for
molecular docking studies. Curr Drug Targets. 17:22016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu QX, Wang XF, Ikeo K, Hirose S, Gehring
WJ and Gojobori T: Evolutionarily conserved transcription factor
Apontic controls the G1/S progression by inducing cyclin E
during eye development. Proc Natl Acad Sci USA. 111:9497–9502.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gladden AB and Diehl JA: Cell cycle
progression without cyclin E/CDK2: Breaking down the walls of
dogma. Cancer Cell. 4:160–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rath SL and Senapati S: Why are the
truncated cyclin Es more effective CDK2 activators than the
full-length isoforms? Biochemistry. 53:4612–4624. 2014. View Article : Google Scholar : PubMed/NCBI
|
